
Charles Atkinson
Examiner (ID: 13902)
| Most Active Art Unit | 2306 |
| Art Unit(s) | 2305, 2604, 2307, 2413, 2306, 2313 |
| Total Applications | 1186 |
| Issued Applications | 1116 |
| Pending Applications | 2 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5813108
[patent_doc_number] => 20060083737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Intracellular peptide delivery'
[patent_app_type] => utility
[patent_app_number] => 11/251956
[patent_app_country] => US
[patent_app_date] => 2005-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6802
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20060083737.pdf
[firstpage_image] =>[orig_patent_app_number] => 11251956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/251956 | Methods of intracellular peptide delivery | Oct 16, 2005 | Issued |
Array
(
[id] => 5672543
[patent_doc_number] => 20060177898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-10
[patent_title] => 'Methods for producing modified glycoproteins'
[patent_app_type] => utility
[patent_app_number] => 11/249061
[patent_app_country] => US
[patent_app_date] => 2005-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13385
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20060177898.pdf
[firstpage_image] =>[orig_patent_app_number] => 11249061
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/249061 | Methods for producing modified glycoproteins | Oct 10, 2005 | Issued |
Array
(
[id] => 5716308
[patent_doc_number] => 20060079671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Phosphoprotein affinity resins and methods for making and using the same'
[patent_app_type] => utility
[patent_app_number] => 11/249151
[patent_app_country] => US
[patent_app_date] => 2005-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7909
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0079/20060079671.pdf
[firstpage_image] =>[orig_patent_app_number] => 11249151
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/249151 | Phosphoprotein affinity resins and methods for making and using the same | Oct 10, 2005 | Issued |
Array
(
[id] => 5720789
[patent_doc_number] => 20060073564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-06
[patent_title] => 'Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)'
[patent_app_type] => utility
[patent_app_number] => 11/244302
[patent_app_country] => US
[patent_app_date] => 2005-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15896
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20060073564.pdf
[firstpage_image] =>[orig_patent_app_number] => 11244302
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/244302 | Nucleic acid molecule encoding a (poly)peptide co-segregating in mutated form with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED) | Oct 3, 2005 | Abandoned |
Array
(
[id] => 5715600
[patent_doc_number] => 20060078963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-13
[patent_title] => 'Methods for producing modified glycoproteins'
[patent_app_type] => utility
[patent_app_number] => 11/240432
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13371
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0078/20060078963.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240432
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240432 | Methods for producing modified glycoproteins | Sep 29, 2005 | Issued |
Array
(
[id] => 4860618
[patent_doc_number] => 20080269468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Devices and Methods for Integrated Continuous Manufacturing of Biological Molecules'
[patent_app_type] => utility
[patent_app_number] => 11/576097
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13342
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269468.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576097
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576097 | Devices and methods for integrated continuous manufacturing of biological molecules | Sep 29, 2005 | Issued |
Array
(
[id] => 545965
[patent_doc_number] => 07164010
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-01-16
[patent_title] => 'Molecular magnetic protein'
[patent_app_type] => utility
[patent_app_number] => 11/237160
[patent_app_country] => US
[patent_app_date] => 2005-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 2716
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/164/07164010.pdf
[firstpage_image] =>[orig_patent_app_number] => 11237160
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/237160 | Molecular magnetic protein | Sep 27, 2005 | Issued |
Array
(
[id] => 657939
[patent_doc_number] => 07105323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-12
[patent_title] => 'Recombinant cage-like protein, method for producing the same, precious metal-recombinant cage-like protein complex, method for producing the same and recombinant DNA'
[patent_app_type] => utility
[patent_app_number] => 11/229240
[patent_app_country] => US
[patent_app_date] => 2005-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12164
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 248
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11229240
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/229240 | Recombinant cage-like protein, method for producing the same, precious metal-recombinant cage-like protein complex, method for producing the same and recombinant DNA | Sep 15, 2005 | Issued |
Array
(
[id] => 373466
[patent_doc_number] => 07473769
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-06
[patent_title] => 'Insect desiccation resistance genes and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/222641
[patent_app_country] => US
[patent_app_date] => 2005-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6707
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/473/07473769.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222641
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222641 | Insect desiccation resistance genes and uses thereof | Sep 7, 2005 | Issued |
Array
(
[id] => 5590904
[patent_doc_number] => 20060040356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins'
[patent_app_type] => utility
[patent_app_number] => 11/222451
[patent_app_country] => US
[patent_app_date] => 2005-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9683
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20060040356.pdf
[firstpage_image] =>[orig_patent_app_number] => 11222451
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/222451 | Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins | Sep 6, 2005 | Abandoned |
Array
(
[id] => 5894881
[patent_doc_number] => 20060003420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Monomeric and dimeric fluorescent protein variants and methods for making same'
[patent_app_type] => utility
[patent_app_number] => 11/218880
[patent_app_country] => US
[patent_app_date] => 2005-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 30275
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003420.pdf
[firstpage_image] =>[orig_patent_app_number] => 11218880
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/218880 | Monomeric and dimeric fluorescent protein variants and methods for making same | Aug 31, 2005 | Abandoned |
Array
(
[id] => 5126380
[patent_doc_number] => 20070238651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'Nucleic acids and proteins of a rat ganglioside GM1-specific alpha1-2fucosyltransferase and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/215356
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21804
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238651.pdf
[firstpage_image] =>[orig_patent_app_number] => 11215356
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/215356 | Nucleic acids and proteins of a rat ganglioside GM1-specific alpha1-2fucosyltransferase and uses thereof | Aug 28, 2005 | Abandoned |
Array
(
[id] => 4455511
[patent_doc_number] => 07892755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-22
[patent_title] => 'Screening method'
[patent_app_type] => utility
[patent_app_number] => 11/661555
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 48242
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/892/07892755.pdf
[firstpage_image] =>[orig_patent_app_number] => 11661555
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/661555 | Screening method | Aug 28, 2005 | Issued |
Array
(
[id] => 5865441
[patent_doc_number] => 20060099571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Stabilized bioactive peptides and methods of identification, synthesis, and use'
[patent_app_type] => utility
[patent_app_number] => 11/213668
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 31094
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20060099571.pdf
[firstpage_image] =>[orig_patent_app_number] => 11213668
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/213668 | Stabilized bioactive peptides and methods of identification, synthesis, and use | Aug 25, 2005 | Issued |
Array
(
[id] => 5678333
[patent_doc_number] => 20060183689
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-17
[patent_title] => 'Activation of peptide prodrugs by hK2'
[patent_app_type] => utility
[patent_app_number] => 11/212028
[patent_app_country] => US
[patent_app_date] => 2005-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8983
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20060183689.pdf
[firstpage_image] =>[orig_patent_app_number] => 11212028
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/212028 | Activation of peptide prodrugs by hK2 | Aug 23, 2005 | Abandoned |
Array
(
[id] => 239281
[patent_doc_number] => 07591996
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-09-22
[patent_title] => 'Ultrasound target vessel occlusion using microbubbles'
[patent_app_type] => utility
[patent_app_number] => 11/206639
[patent_app_country] => US
[patent_app_date] => 2005-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 20
[patent_no_of_words] => 11340
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/591/07591996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11206639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/206639 | Ultrasound target vessel occlusion using microbubbles | Aug 16, 2005 | Issued |
Array
(
[id] => 5154375
[patent_doc_number] => 20070037258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-15
[patent_title] => 'Methods and compositions for enhancing protein folding'
[patent_app_type] => utility
[patent_app_number] => 11/199782
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14127
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20070037258.pdf
[firstpage_image] =>[orig_patent_app_number] => 11199782
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/199782 | Methods and compositions for enhancing protein folding | Aug 8, 2005 | Abandoned |
Array
(
[id] => 4534193
[patent_doc_number] => 07888314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-02-15
[patent_title] => 'Compositions and methods for treating peripheral vascular disease'
[patent_app_type] => utility
[patent_app_number] => 11/198527
[patent_app_country] => US
[patent_app_date] => 2005-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7376
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/888/07888314.pdf
[firstpage_image] =>[orig_patent_app_number] => 11198527
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/198527 | Compositions and methods for treating peripheral vascular disease | Aug 4, 2005 | Issued |
Array
(
[id] => 5075231
[patent_doc_number] => 20070015206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-18
[patent_title] => 'Method for detecting and/or removing protien comprising a cross-beta structure from a pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 11/181040
[patent_app_country] => US
[patent_app_date] => 2005-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 22903
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20070015206.pdf
[firstpage_image] =>[orig_patent_app_number] => 11181040
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181040 | Method for detecting and/or removing a protein comprising a cross-beta structure from a pharmaceutical composition | Jul 12, 2005 | Issued |
Array
(
[id] => 5770610
[patent_doc_number] => 20050266491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent and the use thereof in diagnostics, high throughput screening and novelty items'
[patent_app_type] => utility
[patent_app_number] => 11/179411
[patent_app_country] => US
[patent_app_date] => 2005-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 39323
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266491.pdf
[firstpage_image] =>[orig_patent_app_number] => 11179411
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/179411 | Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent and the use thereof in diagnostics, high throughput screening and novelty items | Jul 11, 2005 | Abandoned |